Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Biogen Inc Breaking News: Investing Merck & Co Inc
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business Economy Politics
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biotech and Pharmaceuticals Science Business
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Health & Science Business Breaking news
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Pultegroup Inc Amgen Inc Trump Media & Technology Group Corp
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Reddit Inc Comcast Corp Uber Technologies Inc
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags WABTEC CORP DRN Live Nation Entertainment Inc stocks
From CNBC.com News
5 things to know before the stock market opens Monday
Tags 5 Things to Know Tesla Inc Investment strategy
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Science Biotech and Pharmaceuticals Breaking news
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Breaking news Breaking News: Earnings Breaking News: Business
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags Biotech and Pharmaceuticals Breaking news Science
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Health & Science Eli Lilly and Co Business
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Eisai Co Ltd Health care industry Companies
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags stocks Business Eli Lilly and Co
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Investment strategy Stock Picks Investment Strategy
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Biotech and Pharmaceuticals Breaking news Business
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Ford Motor Co Bristol/Myers Squibb Co American Airlines Group Inc
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Biotechnology Business News Biogen Inc
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Biogen Inc Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Business Health & Science Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Markets Restaurant Brands International Inc Investing
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags US: News Biogen Inc Business News
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Health care industry Eisai Co Ltd Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Investing Markets
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags Health care industry Eisai Co Ltd Pharmaceuticals
From CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
Tags Biotech and Pharmaceuticals SAGE Therapeutics Inc Breaking news
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
Tags Enphase Energy Inc First Solar Inc Reata Pharmaceuticals Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
Tags Earnings Finance Biogen Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Tags Companies Pharmaceuticals Health care industry
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.